Thread by @DataDrivenMD, Investigative journalists would do well to dig into coordination between HHS, GSA, [...]

Investigative journalists would do well to dig into coordination between HHS, GSA, and Treasury on single-source/no-bid purchases of inaccurate #COVID19 tests totaling more than $175M+

One might begin by asking HHS ASPR, Robert Kadlec, to explain the rationale behind their "requirement to purchase” $174M worth of Abbott ID NOW testing kits.

A follow-up question might be: “Were you aware of the research study showing that these test kits missed nearly half of positive cases?” https://www.cnbc.com/2020/05/13/abbotts-rapid-coronavirus-test-misses-positive-cases-raising-questions-nyu-study-finds.html

Abbott's rapid coronavirus test misses positive cases, raising questions, NYU study finds

The urgency to ramp up coronavirus testing in the U.S. "has eased the usual scrutiny" applied by the Food and Drug Administration before the release of a new test, according to the authors of the...

https://www.cnbc.com/2020/05/13/abbotts-rapid-coronavirus-test-misses-positive-cases-raising-questions-nyu-study-finds.html

It would be worth pressing the issue by asking: Why issue a ’requirement’ to purchase *knowingly* faulty tests 3 weeks *after* the FDA issued a public warning citing multiple reports of problems with this testing platform? https://www.medscape.com/viewarticle/930599

FDA Issues Alert on Accuracy of Abbott ID NOW Rapid Test

Early data suggest that Abbott's rapid test for COVID-19, currently being used to screen White House staff, may give false negative results.

https://www.medscape.com/viewarticle/930599

Why did no such “requirement” exist for tests made by Abbott’s primary competitor despite the fact that both the VA and parts of the Indian Health Service were making their preference clear through repeat orders— before and after the $174M contract.

see: https://projects.propublica.org/coronavirus-contracts/vendors/cepheid

More to the point: Why was there such as disparity in the Trump Administration’s financial commitment to a faulty testing platform despite multiple public reports and an FDA notice?

sources:
https://projects.propublica.org/coronavirus-contracts/vendors/cepheid

https://projects.propublica.org/coronavirus-contracts/vendors/abbott-rapid-dx-north-america-llc

Furthermore: why did HHS deem it appropriate to effectively circumvent the FDA by instructing IHS continue using the Abbott ID NOW system as-is?

https://indiancountrytoday.com/news/fda-warns-of-test-inaccuracies-ihs-finds-acceptable-r-44VHfUGkG8NFYVVwhgFw

Why were medical clinics serving Native communities boxed into going along with HHS (via IHS) vs. siding with the FDA, and experts in the public and private sectors? https://bringmethenews.com/minnesota-news/fond-du-lac-band-stops-using-covid-19-test-over-accuracy-concerns

Fond du Lac Band stops using COVID-19 test over accuracy concerns

The FDA is looking into inaccuracy reports.

https://bringmethenews.com/minnesota-news/fond-du-lac-band-stops-using-covid-19-test-over-accuracy-concerns

Over at GSA: @GSAEmily should explain how this contract does NOT violate FAR 6.302-2, which places clear limits on the use of non-competitive contracts. At least two such limitations appear to be violated in this case.

Src: https://www.acquisition.gov/far/part-6#FAR_6_302_2

Emily should be able to answer: “Why haven’t the justifications for non-competitive purchasing been produced and published as required under FAR 6.302?”

see: https://www.acquisition.gov/far/part-6#FAR_6_302_2

“As a minimum" Emily should be able to provide the “estimated cost, or other rationale as to the extent and nature of the harm to the Government” and “determination that the use of a sole-source contract is in the best interest of the agency concerned”
see https://www.acquisition.gov/far/part-6#FAR_6_303_2

A justification for that $174M not-competed contract is nowhere on HHS, http://SAM.gov , and http://FPDS.gov — a fact that in and of itself is in violation of multiple regulations.

It would be worth asking Emily about this, too.

see: https://www.acquisition.gov/far/part-6#FAR_6_305

If Emily doesn’t have access to the written justifications, there are two individuals over at HHS that can point investigative journalists in the right direction (see image)

While chatting with “along” and/or “awright” at HHS, it would be important to ask them *who* authorized the contract, and to confirm that this person had authority to do so.

After all, that authority cannot be delegated under federal law.

https://www.acquisition.gov/far/part-6#FAR_6_304

While chatting with “along” and/or “awright” at HHS, it would be important to ask them *who* authorized the contract, and to confirm that this person had authority to do so. After all, that authority cannot be delegated under federal law. https://www.acquisition.gov/far/part-6#FAR_6_304

The only person who could legally authorize this contract is *Acting* Assistant Secretary for Financial Resources (ASFR) and *Acting* Chief Financial Officer for HHS, Jennifer Moughalian.

see:
https://www.hhs.gov/about/leadership/jennifer-moughalian/index.html

https://www.hhs.gov/about/agencies/asfr/key-personnel/index.html

While chatting with HHS ASFR/CFO Moughalian, investigative journalists would do well to ask about this other thread that describes a deal worth $100M for #COVID19 testing sites for Iowa

For the same reasons, that contract would need approval at the highest levels of HHS, as well https://twitter.com/DataDrivenMD/status/1326882821877624834

https://twitter.com/DataDrivenMD/status/1326882821877624834

Clarification: HHS ASPR Robert Kadlec may also be able to authorize the contract under the law. So, if journalists can’t reach Moughalian or Kadlec, they should try connecting w/ David M. Kelly (public records link him to #COVID19 purchases for ASPR)

see: https://govtribe.com/file/government-file/grainger-75a50120p00040-hood-sleeve-grainger-signed-3-18-20-dot-pdf

Last (for now) but not least, there’s this peculiar description in contract ID 75A50120C00102, which suggests some level of coordination between senior HHS’s chief financial officer and the Treasury…

see: https://www.usaspending.gov/award/CONT_AWD_75A50120C00102_7505_-NONE-_-NONE-

…This is the only transaction with this annotation that I could find, but there are other sole-source, non-competed contracts that have similar “funding-only” transactions in the 6-8 weeks…

In light of Treasury Sec. Mnuchin’s move to shift money around #COVID19 relief programs, it’s worth asking Mnuchin why the sudden rush? https://www.cnbc.com/2020/11/19/treasury-seeks-to-extend-some-emergency-fed-programs-but-end-others-including-main-street-facility.html

Treasury moves to end several crisis-era programs, drawing pushback from the Fed

The programs were set to expire at the end of the year. They were instituted in early March as markets froze.

https://www.cnbc.com/2020/11/19/treasury-seeks-to-extend-some-emergency-fed-programs-but-end-others-including-main-street-facility.html

In light of a recent GAO report that raises questions about recent rule changes involving PPP funds, Sec. Mnuchin and HHS CFO Moughalian should be asked: why transfer charges from CARES -> PPPHCE?

see:
https://www.gao.gov/products/B-332639#mt=e-report

https://www.wsj.com/articles/ppp-was-a-fraudster-free-for-all-investigators-say-11604832072

https://www.wsj.com/articles/sba-wins-temporary-delay-of-order-to-provide-details-on-ppp-borrowers-11605304678

Small Business Administration, Department of the Treasury: Business Loan Program Temporary Changes;...

GAO reviewed the Small Business Administration (SBA) and Department of the Treasury's (Treasury) new rule entitled "Business Loan Program Temporary Changes; Paycheck Protection Program—Additional...

https://www.gao.gov/products/B-332639#mt=e-report

Taken together:

Trump’s tweet is yet another example of him projecting bad deeds unto others

Trump’s HHS *knowingly* purchased $175M+ worth of inaccurate tests, likely enabled by GSA

Recent actions taken by senior officials at HHS and Treasury departments raise

Fun fact— Alaska is one of the few states that is named specifically in the description field for the contracts related to this thread. Alaska received Cepheid tests (i.e. Abbott’s competitor).

(see https://projects.propublica.org/coronavirus-contracts/contracts/75A50120C00149) https://twitter.com/KellyO/status/1330654857217404929

For anyone who doubts that the outgoing administration would engage in the wrongdoing documented in this thread, consider this bit of news: https://twitter.com/MonicaMedinaDC/status/1331280068270845960

https://twitter.com/MonicaMedinaDC/status/1331280068270845960

You can follow @DataDrivenMD.

Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: